Evidence map›Paper›PMID 41261427›Full record

ArticleCell & bioscience2025

Multi-omics analysis of the HMGB2

Shangshang Hu, Jinwei Lou, Muzi Ding, Yuhan Chen, Jian Qin, Zixuan Liu, Yue Li, QianNi Xiao, Mu Xu, Huiling Sun and 2 more

Abstract read
In one paragraph

Article in Cell & bioscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Shangshang HuGeneral Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, Jiangsu, China.
Jinwei LouSchool of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, 211122, Jiangsu, China.
Muzi DingSchool of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, 211122, Jiangsu, China.
Yuhan ChenSchool of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, 211122, Jiangsu, China.
Jian QinGeneral Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, Jiangsu, China.
Zixuan LiuSchool of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, 211122, Jiangsu, China.
Yue LiSchool of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, 211122, Jiangsu, China.
QianNi XiaoSchool of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, 211122, Jiangsu, China.
Mu XuSchool of Medicine, Southeast University, Nanjing, 210009, Jiangsu, China.
Huiling SunSchool of Medicine, Southeast University, Nanjing, 210009, Jiangsu, China.
Yuqin PanGeneral Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, Jiangsu, China. panyuqin01@163.com.
Shukui WangGeneral Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, Jiangsu, China. sk_wang@njmu.edu.cn.

Funding

Industry-University-Research Innovation Fund for Chinese Universities -digital health project 2023GY014Jiangsu Provincial Medical Key Discipline Cultivation Unit JSDW202239Key Project of Science and Technology Development of Nanjing Medicine ZKX21042the National Natural Science Foundation of China 82272629
6 · The paper itself

Abstract

Colorectal cancer (CRC) is a prevalent malignancy, yet the role of lactylation in its progression remains unclear. This study investigates High Mobility Group Box 2 positive tumor epithelial cells (HMGB2

Indexed as

Colorectal cancerHMGB2LactylationMulti-omics

Identifiers

PMID41261427
PMCPMC12632091

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.